Medistim ASA (MEDI.OL)
NOK 161.0
(1.58%)
NOK 161.0
(1.58%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 9.26 Million NOK | -45.87% |
| 2022 | 17.1 Million NOK | -29.29% |
| 2021 | 24.19 Million NOK | -38.15% |
| 2020 | 39.11 Million NOK | 7.48% |
| 2019 | 36.38 Million NOK | 246.56% |
| 2018 | 10.5 Million NOK | -31.71% |
| 2017 | 15.37 Million NOK | 173.33% |
| 2016 | 5.62 Million NOK | -49.06% |
| 2015 | 11.04 Million NOK | -39.08% |
| 2014 | 18.12 Million NOK | 118.03% |
| 2013 | 8.31 Million NOK | 0.0% |
| 2012 | - NOK | 0.0% |
| 2011 | - NOK | -100.0% |
| 2010 | 3 Million NOK | -57.16% |
| 2009 | 7 Million NOK | -40.67% |
| 2008 | 11.8 Million NOK | -27.23% |
| 2007 | 16.22 Million NOK | 0.0% |
| 2006 | - NOK | 0.0% |
| 2005 | - NOK | 0.0% |
| 2004 | - NOK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 17.36 Million NOK | 87.49% |
| 2024 Q3 | 10 Million NOK | -60.08% |
| 2024 Q2 | 18.72 Million NOK | 7.82% |
| 2023 Q3 | 9.01 Million NOK | -22.96% |
| 2023 Q1 | 9.39 Million NOK | -45.06% |
| 2023 Q2 | 11.7 Million NOK | 24.57% |
| 2023 FY | 9.26 Million NOK | -45.87% |
| 2023 Q4 | 9.26 Million NOK | 2.67% |
| 2022 Q2 | 13.85 Million NOK | -85.64% |
| 2022 FY | 17.1 Million NOK | -29.29% |
| 2022 Q3 | 13.85 Million NOK | 0.0% |
| 2022 Q4 | 17.1 Million NOK | 23.5% |
| 2022 Q1 | 96.47 Million NOK | 298.81% |
| 2021 Q3 | 80.77 Million NOK | 13.73% |
| 2021 Q2 | 71.02 Million NOK | -15.0% |
| 2021 Q4 | 24.19 Million NOK | -70.05% |
| 2021 Q1 | 83.55 Million NOK | 113.62% |
| 2021 FY | 24.19 Million NOK | -38.15% |
| 2020 Q1 | 24.93 Million NOK | -31.47% |
| 2020 Q2 | 22.68 Million NOK | -9.01% |
| 2020 Q3 | 30.65 Million NOK | 35.12% |
| 2020 Q4 | 39.11 Million NOK | 27.58% |
| 2020 FY | 39.11 Million NOK | 7.48% |
| 2019 Q2 | 56.26 Million NOK | 634.56% |
| 2019 Q3 | 59.11 Million NOK | 5.07% |
| 2019 Q4 | 36.38 Million NOK | -38.45% |
| 2019 FY | 36.38 Million NOK | 246.56% |
| 2019 Q1 | 7.66 Million NOK | -27.05% |
| 2018 Q1 | 8.81 Million NOK | -42.68% |
| 2018 Q4 | 10.5 Million NOK | 27.27% |
| 2018 Q2 | 48.43 Million NOK | 449.61% |
| 2018 Q3 | 8.25 Million NOK | -82.97% |
| 2018 FY | 10.5 Million NOK | -31.71% |
| 2017 FY | 15.37 Million NOK | 173.33% |
| 2017 Q4 | 15.37 Million NOK | 36.67% |
| 2017 Q3 | 11.25 Million NOK | -6.25% |
| 2017 Q2 | 12 Million NOK | 0.0% |
| 2017 Q1 | - NOK | -100.0% |
| 2016 Q3 | 3.66 Million NOK | -2.29% |
| 2016 FY | 5.62 Million NOK | -49.06% |
| 2016 Q2 | 3.75 Million NOK | -32.08% |
| 2016 Q4 | 5.62 Million NOK | 53.52% |
| 2016 Q1 | 5.52 Million NOK | -50.0% |
| 2015 FY | 11.04 Million NOK | -39.08% |
| 2015 Q1 | 9.27 Million NOK | -48.84% |
| 2015 Q2 | 9.22 Million NOK | -0.5% |
| 2015 Q3 | 5.73 Million NOK | -37.88% |
| 2015 Q4 | 11.04 Million NOK | 92.67% |
| 2014 Q3 | 12.79 Million NOK | -12.16% |
| 2014 Q1 | 4.14 Million NOK | -50.1% |
| 2014 FY | 18.12 Million NOK | 118.03% |
| 2014 Q4 | 18.12 Million NOK | 41.67% |
| 2014 Q2 | 14.56 Million NOK | 251.13% |
| 2013 Q4 | 8.31 Million NOK | -9.12% |
| 2013 Q2 | 9.98 Million NOK | 0.0% |
| 2013 Q1 | - NOK | 0.0% |
| 2013 FY | 8.31 Million NOK | 0.0% |
| 2013 Q3 | 9.14 Million NOK | -8.35% |
| 2012 Q2 | - NOK | 0.0% |
| 2012 Q1 | - NOK | 0.0% |
| 2012 Q3 | - NOK | 0.0% |
| 2012 FY | - NOK | 0.0% |
| 2012 Q4 | - NOK | 0.0% |
| 2011 Q2 | - NOK | 0.0% |
| 2011 Q4 | - NOK | 0.0% |
| 2011 FY | - NOK | -100.0% |
| 2011 Q1 | - NOK | -100.0% |
| 2011 Q3 | - NOK | 0.0% |
| 2010 FY | 3 Million NOK | -57.16% |
| 2010 Q3 | - NOK | 0.0% |
| 2010 Q2 | - NOK | 0.0% |
| 2010 Q1 | - NOK | -100.0% |
| 2010 Q4 | 3 Million NOK | 0.0% |
| 2009 FY | 7 Million NOK | -40.67% |
| 2009 Q4 | 7 Million NOK | 0.0% |
| 2008 FY | 11.8 Million NOK | -27.23% |
| 2007 FY | 16.22 Million NOK | 0.0% |
| 2006 FY | - NOK | 0.0% |
| 2005 FY | - NOK | 0.0% |
| 2004 FY | - NOK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Gentian Diagnostics ASA | 9 Million NOK | -2.82% |
| Lifecare AS | 6.45 Million NOK | -43.561% |